Product NDC: | 0024-5841 |
Proprietary Name: | ZALTRAP |
Non Proprietary Name: | ziv-aflibercept |
Active Ingredient(s): | 200 mg/8mL & nbsp; ziv-aflibercept |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-5841 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125418 |
Marketing Category: | BLA |
Start Marketing Date: | 20120803 |
Package NDC: | 0024-5841-01 |
Package Description: | 1 VIAL in 1 CARTON (0024-5841-01) > 8 mL in 1 VIAL |
NDC Code | 0024-5841-01 |
Proprietary Name | ZALTRAP |
Package Description | 1 VIAL in 1 CARTON (0024-5841-01) > 8 mL in 1 VIAL |
Product NDC | 0024-5841 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ziv-aflibercept |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120803 |
Marketing Category Name | BLA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | ZIV-AFLIBERCEPT |
Strength Number | 200 |
Strength Unit | mg/8mL |
Pharmaceutical Classes |